Alli Labels In U.S. Add Seizure Advisory Similar To E.U. Change
This article was originally published in The Tan Sheet
GSK also recently posted to the alli brand website statements on why language was added to the Drug Facts panel for the orlistat 60 mg product. FDA contacted Glaxo in November 2013 requesting a supplement NDA for the label change, FDA’s Division of Nonprescription Clinical Evaluation said.